Kuehn Law Encourages DSKE, RYZB, ROVR, and GRPH Investors to Contact Law Firm
NEW YORK, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers.
- NEW YORK, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers.
- Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.
- Bristol Myers Squibb has agreed to purchase RayzeBio in an all-cash deal valued at around $4.1 billion.
- Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at [email protected] or call (833) 672-0814.